Trials / Conditions / Lymphatic Malformations

Lymphatic Malformations

11 registered clinical trials studyying Lymphatic Malformations — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Comm NCT07285005	Kaken Pharmaceutical	Phase 3
Recruiting	A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Over NCT06789913	Relay Therapeutics, Inc.	Phase 2
Completed	Bleomycin Intralesional Injections of Cystic Hygromas NCT07189832	Delta University for Science and Technology	N/A
Recruiting	Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation. NCT05948943	Novartis Pharmaceuticals	Phase 2 / Phase 3
Completed	Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma NCT06943703	National Children's Hospital, Vietnam	—
Completed	Sildenafil for the Treatment of Lymphatic Malformations NCT02335242	Stanford University	Phase 2
Terminated	Selenium in the Treatment of Complicated Lymphatic Malformations NCT01212965	Medical College of Wisconsin	Phase 1
Completed	Diagnosis of Hemangiomas and Vascular Malformations NCT00577213	University of Arkansas	—
Completed	OK432 (Picibanil) in the Treatment of Lymphatic Malformations NCT03427619	Richard JH Smith	Phase 2
Completed	Airway Vascular Lesions NCT00866827	University of Arkansas	—
Completed	Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations NCT00010452	University of Iowa	Phase 2 / Phase 3